Pace, E.; Cerveri, I.; Lacedonia, D.; Paone, G.; Sanduzzi Zamparelli, A.; Sorbo, R.; Allegretti, M.; Lanata, L.; Scaglione, F.
Clinical Efficacy of Carbocysteine in COPD: Beyond the Mucolytic Action. Pharmaceutics 2022, 14, 1261.
https://doi.org/10.3390/pharmaceutics14061261
AMA Style
Pace E, Cerveri I, Lacedonia D, Paone G, Sanduzzi Zamparelli A, Sorbo R, Allegretti M, Lanata L, Scaglione F.
Clinical Efficacy of Carbocysteine in COPD: Beyond the Mucolytic Action. Pharmaceutics. 2022; 14(6):1261.
https://doi.org/10.3390/pharmaceutics14061261
Chicago/Turabian Style
Pace, Elisabetta, Isa Cerveri, Donato Lacedonia, Gregorino Paone, Alessandro Sanduzzi Zamparelli, Rossella Sorbo, Marcello Allegretti, Luigi Lanata, and Francesco Scaglione.
2022. "Clinical Efficacy of Carbocysteine in COPD: Beyond the Mucolytic Action" Pharmaceutics 14, no. 6: 1261.
https://doi.org/10.3390/pharmaceutics14061261
APA Style
Pace, E., Cerveri, I., Lacedonia, D., Paone, G., Sanduzzi Zamparelli, A., Sorbo, R., Allegretti, M., Lanata, L., & Scaglione, F.
(2022). Clinical Efficacy of Carbocysteine in COPD: Beyond the Mucolytic Action. Pharmaceutics, 14(6), 1261.
https://doi.org/10.3390/pharmaceutics14061261
